Rare diseases
Investigational molecules
Locations
Back to Czechia73 clinical trials in Brno-Zidenice, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis
CzechiaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
CzechiaA Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis
CzechiaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaEfficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
CzechiaStudy of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
CzechiaComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
CzechiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
CzechiaEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
CzechiaStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments
CzechiaStudy on the Effects of LNA043 for Patients with Knee Osteoarthritis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
In Brno-Zidenice, cardiovascular research is strongly represented, with studies focused on heart failure, atrial fibrillation, acute coronary syndromes, hypertension, and broader atherosclerotic cardiovascular disease. These trials are designed to test new treatment options, reduce major cardiovascular events, and improve long-term heart and circulation outcomes.
Much of this work aims to improve protection against hospitalization, stroke, and cardiovascular death, while also supporting safer, more effective care for people living with chronic heart conditions.
Clinical trials in digestive system diseases are especially active, covering Crohn’s disease, ulcerative colitis, coeliac disease, and gastroesophageal reflux disease. Researchers are primarily looking at whether new treatments can better control inflammation, promote remission, and improve everyday digestive symptoms.
This area reflects a broad effort to advance both induction and maintenance treatments for inflammatory bowel conditions, as well as better options for upper digestive tract disease.
Immune-focused studies in this city explore conditions such as psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, giant cell arteritis, and polymyalgia rheumatica. The main goal is to understand how new immune-targeted therapies can reduce inflammation, improve mobility, and ease persistent disease symptoms.
These trials support the search for more precise therapies that can calm immune-driven inflammation while helping patients maintain function and quality of life.
Research in musculoskeletal diseases overlaps with inflammatory joint disorders and includes studies in osteoarthritis, juvenile idiopathic arthritis, and related spine and joint conditions. The focus is on easing pain, improving joint function, and finding treatments that can slow disease impact over time.
These studies aim to broaden options for patients whose daily activities are affected by chronic joint inflammation or degenerative joint damage.
Trials in nutritional and metabolic diseases address obesity, overweight, type 2 diabetes, and complications linked to cardiometabolic risk. They are designed to explore whether new approaches can improve weight-related health, lower cardiovascular risk, and support better metabolic control.
These studies often connect metabolic health with heart protection, reflecting the close relationship between weight, blood sugar, and cardiovascular disease.
In the field of skin and connective tissue diseases, trials are centered on psoriasis and inflammatory conditions that affect both skin and joints. Researchers are evaluating new therapies that may better control visible symptoms while also addressing deeper immune activity.
These studies highlight the need for therapies that can manage both the physical burden and the long-term inflammatory nature of these conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
